{
    "id": "72",
    "title": "WPSS (WHO classification-based Prognostic Scoring System) for Myelodysplastic Syndrome",
    "desc": "The WPSS (WHO classification-based Prognostic Scoring System) for Myelodysplastic Syndrome evaluates the prognosis of patients with MDS.",
    "data": {
        "orgreference": [
            {
                "href": "http://www.bloodjournal.org/content/106/11/788?sso-checked=true ",
                "text": "Malcovati L, et al. A WHO Classification-Based Prognostic Scoring System (WPSS) for Predicting Survival in Myelodysplastic Syndromes. Blood. 2005; 106(11)."
            }
        ],
        "other_refer": [
            {
                "href": "",
                "text": ""
            }
        ],
        "evidence": "<p dir=\"ltr\">Addition of the selected points:</p>\n<div dir=\"ltr\">\n<table><colgroup><col width=\"*\" /><col width=\"*\" /><col width=\"*\" /><col width=\"*\" /><col width=\"*\" /></colgroup>\n<tbody>\n<tr>\n<td>\n<p dir=\"ltr\"><strong>Prognostic variable</strong></p>\n</td>\n<td>\n<p dir=\"ltr\"><strong>0 points</strong></p>\n</td>\n<td>\n<p dir=\"ltr\"><strong>1 point</strong></p>\n</td>\n<td>\n<p dir=\"ltr\"><strong>2 points</strong></p>\n</td>\n<td>\n<p dir=\"ltr\"><strong>3 points </strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">WHO category</p>\n</td>\n<td>\n<p dir=\"ltr\">Refractory anemia (RA), refractory anemia with ringed sideroblasts (RARS), or myelodysplastic syndrome with isolated del (5q)</p>\n</td>\n<td>\n<p dir=\"ltr\">Refractory cytopenia with multilineage dysplasia (RCMD), or refractory cytopenia with multilineage dysplasia and ringed sideroblasts (RCMD-RS)</p>\n</td>\n<td>\n<p dir=\"ltr\">Refractory anemia with excess of blasts, 2-4% blasts in peripheral blood (RAEB-1)</p>\n</td>\n<td>\n<p dir=\"ltr\">Refractory anemia with excess of blasts,&nbsp;5-19% blasts in peripheral blood (RAEB-2)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">Karyotype*</p>\n</td>\n<td>\n<p dir=\"ltr\">Good</p>\n</td>\n<td>\n<p dir=\"ltr\">Intermediate</p>\n</td>\n<td>\n<p dir=\"ltr\">Poor</p>\n</td>\n<td>\n<p dir=\"ltr\">--</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">Transfusion requirement**</p>\n</td>\n<td>\n<p dir=\"ltr\">None</p>\n</td>\n<td>\n<p dir=\"ltr\">Regular</p>\n</td>\n<td>\n<p dir=\"ltr\">--</p>\n</td>\n<td>\n<p dir=\"ltr\">--</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>\u0001*Karyotype is defined as follows: good = normal, &ndash;Y, del(5q), del(20q); poor = complex (\u0001&ge;3 abnormalities), chromosome 7 anomalies; and intermediate = all other abnormalities.</p>\n<p>**Transfusion requirement is defined as having at least one RBC transfusion every 8 weeks over a period of 4 months.</p>\n</div>",
        "facts": "<p dir=\"ltr\">Interpretation:</p>\n<div dir=\"ltr\">\n<table><colgroup><col width=\"60\" /><col width=\"107\" /><col width=\"115\" /></colgroup>\n<tbody>\n<tr>\n<td>\n<p dir=\"ltr\"><strong>WPSS Score</strong></p>\n</td>\n<td>\n<p dir=\"ltr\"><strong>Risk group</strong></p>\n</td>\n<td>\n<p dir=\"ltr\"><strong>Median survival</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">0</p>\n</td>\n<td>\n<p dir=\"ltr\">Very low</p>\n</td>\n<td>\n<p dir=\"ltr\">141 months</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">1</p>\n</td>\n<td>\n<p dir=\"ltr\">Low</p>\n</td>\n<td>\n<p dir=\"ltr\">66&nbsp;months</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">2</p>\n</td>\n<td>\n<p dir=\"ltr\">Intermediate</p>\n</td>\n<td>\n<p dir=\"ltr\">48 months</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">3-4</p>\n</td>\n<td>\n<p dir=\"ltr\">High</p>\n</td>\n<td>\n<p dir=\"ltr\">26 months</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">5-6</p>\n</td>\n<td>\n<p dir=\"ltr\">Very high</p>\n</td>\n<td>\n<p dir=\"ltr\">9&nbsp;months</p>\n</td>\n</tr>\n</tbody>\n</table>\n</div>",
        "estimation": [],
        "primary_complains": [
            "Bleeding"
        ],
        "disease_treated": [
            "Cancer",
            "Hematologic Malignancy"
        ],
        "logic": "var calc_output = [];\n\nvar who = parseFloat(who);\nvar karyotype = parseFloat(karyotype);\nvar transfusion = parseFloat(transfusion);\n\nvar score = who + karyotype + transfusion;\n\nvar risk = ''\nvar survival = ''\n\nif (score == 0) {\n\trisk = 'Very low';\n\tsurvival = '141';\n}\nelse if (score == 1) {\n\trisk = 'Low';\n\tsurvival = '66';\n}\nelse if (score == 2) {\n\trisk = 'Intermediate';\n\tsurvival = '48';\n}\nelse if (score == 3 || score == 4) {\n\trisk = 'High';\n\tsurvival = '26';\n}\nelse {\n\trisk = 'Very high';\n\tsurvival = '9';\n}\n\n//results \ncalc_output.push({\n    name: 'mini',\n    value: risk,\n    value_text: ' risk',\n    message: survival + ' months median survival'\n    });\ncalc_output.push({\n    name: 'score',\n    value: score,\n    value_text: 'points',\n    message: 'WPSS for MDS'\n    });\ncalc_output.push({\n    name: 'risk',\n    value: risk,\n    value_text: '',\n    message: 'Risk group'  \n    });\ncalc_output.push({\n    name: 'survival',\n    value: survival,\n    value_text: 'months',\n    message: 'Median survival'\n    });\n",
        "inputs": [
            {
                "conditionality": "",
                "default": 0,
                "label_en": "WHO category",
                "name": "who",
                "optional": false,
                "options": [
                    {
                        "label": "Refractory anemia (RA), refractory anemia with ringed sideroblasts (RARS), or myelodysplastic syndrome with isolated del (5q)",
                        "value": 0
                    },
                    {
                        "label": "Refractory cytopenia with multilineage dysplasia (RCMD), or refractory cytopenia with multilineage dysplasia and ringed sideroblasts (RCMD-RS)",
                        "value": 1
                    },
                    {
                        "label": "Refractory anemia with excess of blasts, 2-4% blasts in peripheral blood (RAEB-1)",
                        "value": 2
                    },
                    {
                        "label": "Refractory anemia with excess of blasts, 5-19% blasts in peripheral blood (RAEB-2)",
                        "value": 3
                    }
                ],
                "show_points": true,
                "type": "radio"
            },
            {
                "conditionality": "",
                "default": 0,
                "label_en": "Karyotype",
                "name": "karyotype",
                "optional": false,
                "options": [
                    {
                        "label": "Good",
                        "value": 0
                    },
                    {
                        "label": "Intermediate",
                        "value": 1
                    },
                    {
                        "label": "Poor",
                        "value": 2
                    }
                ],
                "show_points": true,
                "tips_en": "Defined as follows: good = normal, –Y, del(5q), del(20q); poor = complex (\u0001≥3 abnormalities), chromosome 7 anomalies; and intermediate = all other abnormalities",
                "type": "radio"
            },
            {
                "conditionality": "",
                "default": 0,
                "label_en": "Transfusion requirement",
                "name": "transfusion",
                "optional": false,
                "options": [
                    {
                        "label": "None",
                        "value": 0
                    },
                    {
                        "label": "Regular",
                        "value": 1
                    }
                ],
                "show_points": true,
                "tips_en": "Defined as having at least one RBC transfusion every 8 weeks over a period of 4 months",
                "type": "radio"
            }
        ],
        "can_search": [
            "MDS",
            "WHO MDS scoring",
            "WPSS",
            "Myelodysplastic Syndrome"
        ],
        "specialty": [
            "Hematology and Oncology"
        ]
    }
}